Detalles de la búsqueda
1.
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis.
Antimicrob Agents Chemother
; 68(5): e0158423, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526046
2.
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Lancet
; 401(10370): 49-59, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36442484
3.
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need.
Clin Infect Dis
; 77(3): 380-387, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021650
4.
Metabolism, Excretion, and Mass Balance of [14C]-Rezafungin in Animals and Humans.
Antimicrob Agents Chemother
; 66(1): e0139021, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662192
5.
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial.
Clin Infect Dis
; 73(11): e3647-e3655, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955088
6.
CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial.
J Low Genit Tract Dis
; 23(3): 226-229, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30893271
7.
Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.
Antimicrob Agents Chemother
; 62(6)2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29555634
8.
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.
Clin Infect Dis
; 64(2): 214-217, 2017 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28003218
9.
Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27919901
10.
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264845
11.
Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
J Infect Dis
; 207(11): 1646-54, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23447696
12.
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects.
Pharmacotherapy
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38840536
13.
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials.
Lancet Infect Dis
; 24(3): 319-328, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38008099
14.
Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations.
Microbiol Spectr
; 11(3): e0133923, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37154682
15.
The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study.
Malar J
; 11: 90, 2012 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22453048
16.
Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.
J Trop Pediatr
; 58(3): 194-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21930666
17.
A phase I randomized, double-blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects.
Clin Transl Sci
; 15(7): 1592-1598, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35439347
18.
Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria.
Antimicrob Agents Chemother
; 55(6): 2629-35, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21383095
19.
Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects.
Clin Pharmacol Drug Dev
; 9(4): 456-465, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31793231
20.
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
Clin Infect Dis
; 49(11): 1629-37, 2009 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19877969